{
  "ptid_time": "033_S_0906_2006-09-25",
  "img_path": "/data/qiuhui/data/adni/images/033_S_0906/2006-09-25/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 16,833 mm³, 24.6% below the reference mean. With a Z-score of -0.62 (26.9th percentile), this represents normal volume ; hippocampal volume measures 6,796 mm³, 11.6% below the reference mean. With a Z-score of -1.30 (9.7th percentile), this represents mild atrophy; whole brain volume measures 990,188 mm³, 3.8% below the reference mean. With a Z-score of -0.47 (31.9th percentile), this represents normal volume ; entorhinal cortex volume measures 2,814 mm³, 27.7% below the reference mean. With a Z-score of -2.15 (1.6th percentile), this represents significant atrophy; fusiform gyrus volume measures 17,077 mm³, 6.2% below the reference mean. With a Z-score of -0.70 (24.2th percentile), this represents normal volume ; middle temporal gyrus volume measures 17,501 mm³, 14.7% below the reference mean. With a Z-score of -1.31 (9.6th percentile), this represents mild atrophy. ",
  "text_data": "Age is 65.3 years. Gender is Female. Education: 12 years. Handedness: Right. Race: White. Medical history: Psychiatric; Neurologic; Cardiovascular; Musculoskeletal; Endocrine-Metabolic; Allergies or Drug Sensitivities; Major Surgical Procedures. MMSE: 25.0. Logical Memory: 4.0. APOEε4 alleles: 1.0. Biomarker levels: Amyloid beta: 908.90 pg/mL (normal ); Total tau: 336.40 pg/mL (mild elevated); Phosphorylated tau: 32.63 pg/mL (mild elevated). ",
  "true_diagnosis": "Diagnosis: MCI.",
  "gpt_diagnosis": "**Reasoning:** The imaging data shows significant atrophy in the entorhinal cortex (Z-score -2.15, 1.6th percentile) and mild atrophy in the hippocampus (Z-score -1.30, 9.7th percentile) and middle temporal gyrus (Z-score -1.31, 9.6th percentile), which are key regions affected in Alzheimer's disease. The MMSE score of 25 is borderline, and the CSF biomarkers show normal Aβ but mildly elevated T-tau and P-tau, suggesting possible early neurodegenerative changes.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (likely due to Alzheimer’s pathology given the atrophy pattern and CSF profile).  \n\n**Confidence:** **Medium** (due to borderline MMSE and lack of clear functional decline, but strong structural and biomarker evidence of early neurodegeneration).",
  "timestamp": "2025-07-26T05:20:51.130544"
}